Does Neurologic Examination During Inpatient Rehabilitation Help Predict Global Outcome After Nonpenetrating Traumatic Brain Injury?

W. Walker,S. McDonald

DOI: https://doi.org/10.1016/j.pmrj.2010.11.001

2011-01-01

Abstract:

What problem does this paper attempt to address?

An Oncoprotein CREPT Functions As a Co-Factor in MYC-driven Transformation and Tumor Growth

Mengdi Li,Jingya Li,Chunhua He,Guancheng Jiang,Danhui Ma,Haipeng Guan,Yuting Lin,Meng Li,Jing Jia,Xiaolin Duan,Yinyin Wang,Fangli Ren,Haitao Li,Xiaoguang Wang,Chenxi Cao,Zhijie Chang

DOI: https://doi.org/10.1016/j.jbc.2024.108030

2024-01-01

Abstract:Understanding the mechanisms behind MYC-driven oncogenic transformation could pave the way for identifying novel drug targets. This study explored the role of CREPT in MYC-induced malignancy by generating MYC-transformed mouse embryonic fibroblasts (MEFs) with conditional CREPT deletion. Our results demonstrated that the loss of CREPT significantly impaired MYC-induced colony formation and cell proliferation, indicating that CREPT is essential for the malignant transformation of MEFs. Reintroducing CREPT in CREPT-deficient cells restored malignant properties. Furthermore, CREPT overexpression alone enhanced colony formation upon MYC induction but was insufficient to induce transformation without MYC, suggesting a cooperative interaction between CREPT and MYC in malignant transformation. CREPT deletion resulted in delayed cell cycle progression during the G2/M and S phases. CREPT enhanced the expression of MYC target genes by directly interacting with MYC through the CID domain of CREPT and the PEST domain of MYC. Arginine 34 of CREPT was identified as a critical residue for the interaction with MYC, and its mutation lost the ability of CREPT to promote MYC-driven colony formation and tumor growth in colorectal cancer models. Additionally, CREPT facilitated the recruitment of RNA Polymerase II (RNAPII) to MYC-binding promoters, promoting transcriptional initiation of MYC-targeted genes. Our study also revealed a strong correlation between CREPT and MYC expression in various human cancers, particularly in colorectal cancer, where their interaction appears to play a significant role in tumorigenesis. These findings suggest that the CREPT-MYC interaction is crucial for the progression of MYC-driven cancers and presents a potential target for therapeutic intervention.
miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase.

Kun Wang,Xuan Wang,Jian Zou,Anling Zhang,Yingfeng Wan,Peiyu Pu,Zhengfei Song,Cong Qian,Yili Chen,Shuxu Yang,Yirong Wang

DOI: https://doi.org/10.1093/neuonc/not004

2013-01-01

Neuro-Oncology

Abstract:Nemo-like kinase (NLK) is an evolutionarily conserved protein kinase involved in Wnt/beta-catenin signaling, which has been reported to be associated with gliomagenesis. In the present study, we aimed to identify a concrete mechanism of Wnt/beta-catenin pathway regulation by microRNAs (miRNAs) in glioma. Quantitative reverse-transcription polymerase chain reaction and in situ hybridization were conducted to detect the expression of miR-92b. The cell proliferation rate and cell cycle kinetics were detected using 3-(4,5)-dimethylthiahiazo (-z-y1)-3,5-di-phenytetrazoliumromide (MTT) assay and flow cytometry, cell invasion and migration were evaluated using Transwell assay and wound healing assay, and cell apoptosis was detected using annexin V staining. Furthermore, the relevant molecules regulating proliferation and invasion were examined using Western blot analysis, immunohistochemistry, and immunofluorescence staining. Luciferase reporter assay was used to identify the direct regulation of NLK by miR-92b and beta-catenin/TCF4 activity. We first showed that the expression of miR-92b was elevated in both glioma samples and glioma cells. Furthermore, down-regulation of miR-92b triggered growth inhibition, induced apoptosis, and suppressed invasion of glioma in vitro and in vivo. Luciferase assay and Western blot analysis revealed that NLK is a direct target of miR-92b. Restoring expression of NLK inhibited glioma proliferation and invasion. Mechanistic investigation revealed that miR-92b deletion suppressed beta-catenin/TCF-4 transcription activity by targeting NLK. Moreover, expression of NLK was inversely correlated with miR-92b in glioma samples and was predictive of patient survival in a retrospective analysis. Our findings identify a role for miR-92b in glioma proliferation and invasion after activation of Wnt/beta-catenin signaling via NLK.
CREPT Promotes Melanoma Progression Through Accelerated Proliferation and Enhanced Migration by RhoA-Mediated Actin Filaments and Focal Adhesion Formation

Hui Liu,Ann L. B. Seynhaeve,Rutger W. W. Brouwer,Wilfred F. J. van IJcken,Liu Yang,Yinyin Wang,Zhijie Chang,Timo L. M. ten Hagen

DOI: https://doi.org/10.3390/cancers12010033

2020-01-01

Cancers

Abstract:Melanoma is one of the most aggressive cancers, and patients with distant metastases have dire outcomes. We observed previously that melanoma progression is driven by a high migratory potential of melanoma cells, which survive and proliferate under harsh environmental conditions. In this study, we report that CREPT (cell-cycle related and expression-elevated protein in tumor), an oncoprotein highly expressed in other cancers, is overexpressed in melanoma cells but not melanocytes. Overexpression of CREPT stimulates cell proliferation, migration, and invasion in several melanoma cell lines. Further, we show that CREPT enhances melanoma progression through upregulating and activating Ras homolog family member A (RhoA)-induced actin organization and focal adhesion assembly. Our study reveals a novel role of CREPT in promoting melanoma progression. Targeting CREPT may be a promising strategy for melanoma treatment.
CREPT accelerates tumorigenesis by regulating the transcription of cell-cycle-related genes.

Dongdong Lu,Yinyuan Wu,Yinyin Wang,Fangli Ren,Dianjun Wang,Fuqin Su,Yanquan Zhang,Xi Yang,Guihua Jin,Xinbao Hao,Dacheng He,Yonggong Zhai,David M Irwin,Jim Hu,Joseph J Y Sung,Jun Yu,Baoqing Jia,Zhijie Chang

DOI: https://doi.org/10.1016/j.ccr.2011.12.016

IF: 50.3

2012-01-01

Cancer Cell

Abstract:Tumorigenesis is caused by an uncontrolled cell cycle and the altered expression of many genes. Here, we report a gene CREPT that is preferentially expressed in diverse human tumors. Overexpression of CREPT accelerates tumor growth, whereas depletion of CREPT demonstrates a reversed effect. CREPT regulates cyclin D1 expression by binding to its promoter, enhancing its transcription both in vivo and in vitro, and interacting with RNA polymerase II (RNAPII). Interestingly, CREPT promotes the formation of a chromatin loop and prevents RNAPII from reading through the 3′ end termination site of the gene. Our findings reveal a mechanism where CREPT increases cyclin D1 transcription during tumorigenesis, through enhancing the recruitment of RNAPII to the promoter region, possibly, as well as chromatin looping.
CREPT facilitates colorectal cancer growth through inducing Wnt/β-catenin pathway by enhancing p300-mediated β-catenin acetylation

Yanquan Zhang,Shiyan Wang,Wei Kang,Chunxiao Liu,Yujuan Dong,Fangli Ren,Yinyin Wang,Jinglin Zhang,Guoping Wang,Ka Fai To,Xueji Zhang,Joseph Jy Sung,Zhijie Chang,Jun Yu

DOI: https://doi.org/10.1038/s41388-018-0161-z

IF: 8.756

Oncogene

Abstract:Using whole genome sequencing, we identified gene amplification of CREPT in colorectal cancer (CRC). In this study, we aim to clarify its clinical significance, biological effects, and mechanism in CRC. CREPT was upregulated in CRC cell lines and in 47.37% (72/152) of primary CRC tumors. Amplification of CREPT was detected in 48.28% (56/116) of primary CRC tumors, which was positively correlated with its overexpression (P < 0.001). Multivariate analysis showed that CRC patients with CREPT protein overexpression were significantly associated with poor disease-free survival (P < 0.05). CREPT significantly accelerated CRC cell proliferation and metastasis both in vitro and in vivo. RNA-sequencing (seq) analysis uncovered that the tumor-promoting effect by CREPT was attributed to enhancing Wnt/β-catenin signaling. Using co-immunoprecipitation coupled with mass spectroscopy, we identified p300 protein was a novel CREPT interacting partner. CREPT greatly increased the interaction between p300 and β-catenin, thus promoting p300-mediated β-catenin acetylation and stabilization. Moreover, CREPT cooperated with p300, leading to elevated active histone acetylation markers H3K27ac and H4Ac and decreased repressive histone marker H3K9me3 at the promoters of Wnt downstream targets. In summary, CREPT plays a pivotal oncogenic role in colorectal carcinogenesis through promoting Wnt/β-catenin pathway via cooperating with p300. CREPT may serve as a prognostic biomarker of patients with CRC.
MicroRNA-449b-5p suppresses the growth and invasion of breast cancer cells via inhibiting CREPT-mediated Wnt/β-catenin signaling

Jue Jiang,Xiaoyun Yang,Xin He,Wenqi Ma,Juan Wang,Qi Zhou,Miao Li,Shanshan Yu

DOI: https://doi.org/10.1016/j.cbi.2019.02.004

2019-04-01

Abstract:Accumulating evidence has suggested that microRNA-449b-5p (miR-449b-5p) plays an important role in the development and progression of multiple cancers. However, little is known about the role of miR-449b-5p in breast cancer. In this study, we aimed to investigate the expression level, biological function and underlying mechanism of miR-449b-5p in breast cancer. Our results showed that miR-449b-5p expression was frequently down-regulated in breast cancer cell lines and tissues. The overexpression of miR-449b-5p significantly inhibited growth and invasion, and induced the cell cycle arrest of breast cancer cells. In contrast, the inhibition of miR-449b-5p showed the opposite effect. Interestingly, bioinformatic analysis predicted that cell cycle-related and expression-elevated protein in tumor (CREPT), an important oncogene in breast cancer, was a potential target gene of miR-449b-5p. The overexpression of miR-449b-5p decreased CREPT expression while miR-449b-5p inhibition promoted CREPT expression in breast cancer cells. Restoration of CREPT expression in miR-449b-5p mimics transfected cells partially reversed the suppressive effect of miR-449b-5p on breast cancer cell growth and invasion. Notably, our results showed that miR-449b-5p overexpression decreased the expression of β-catenin and suppressed the activation of Wnt/β-catenin/TCF-4 signaling via targeting CREPT. In addition, blocking Wnt/β-catenin partially reversed the promotion effect of miR-449b-5p inhibition on breast cancer cell growth and invasion. Overall, these results reveal a tumor suppressive role of miR-449b-5p that restricts the growth and invasion of breast cancer cells through targeting CREPT and inhibiting CREPT-mediated activation of Wnt/β-catenin signaling. Our study suggests that the miR-449b-5p/CREPT/Wnt/β-catenin axis may play an important role in the pathogenesis of breast cancer and miR-449-5p may serve as a potential therapeutic target for breast cancer.
Crept/Rprd1b, A Recently Identified Novel Protein Highly Expressed in Tumors, Enhances the Beta-Catenin Center Dot Tcf4 Transcriptional Activity in Response to Wnt Signaling

Yanquan Zhang,Chunxiao Liu,Xiaolin Duan,Fangli Ren,Shan Li,Zhe Jin,Yinyin Wang,Yarui Feng,Zewen Liu,Zhijie Chang

DOI: https://doi.org/10.1074/jbc.m114.560979

IF: 5.485

2014-01-01

Journal of Biological Chemistry

Abstract:CREPT (cell cycle-related and expression elevated protein in tumor)/RPRD1B (regulation of nuclear pre-mRNA domain-containing protein 1B), highly expressed during tumorigenesis, was shown to enhance transcription of CCND1 and to promote cell proliferation by interacting with RNA polymerase II. However, which signaling pathway is involved in CREPT-mediated activation of gene transcription remains unclear. In this study, we reveal that CREPT participates in transcription of the Wnt/beta-catenin signaling activated genes through the beta-catenin and the TCF4 complex. Our results demonstrate that CREPT interacts with both beta-catenin and TCF4, and enhances the association of beta-catenin with TCF4, in response to Wnt stimulation. Furthermore, CREPT was shown to occupy at TCF4 binding sites (TBS) of the promoters of Wnt-targeted genes under Wnt stimulation. Interestingly, depletion of CREPT resulted in decreased occupancy of beta-catenin on TBS, and over-expression of CREPT enhances the activity of the beta-catenin center dot TCF4 complex to initiate transcription of Wnt target genes, which results in up-regulated cell proliferation and invasion. Our study suggests that CREPT acts as an activator to promote transcriptional activity of the beta-catenin center dot TCF4 complex in response to Wnt signaling.
CREPT/RPRD1B, a Recently Identified Novel Protein Highly Expressed in Tumors, Enhances the Β-Catenin·tcf4 Transcriptional Activity in Response to Wnt Signaling.

Yanquan Zhang,Chunxiao Liu,Xiaolin Duan,Fangli Ren,Shan Li,Zhe Jin,Yinyin Wang,Yarui Feng,Zewen Liu,Zhijie Chang

DOI: https://doi.org/10.1074/jbc.m114.560979

2014-01-01

Abstract:CREPT (cell cycle-related and expression elevated protein in tumor)/RPRD1B (regulation of nuclear pre-mRNA domain-containing protein 1B), highly expressed during tumorigenesis, was shown to enhance transcription of CCND1 and to promote cell proliferation by interacting with RNA polymerase II. However, which signaling pathway is involved in CREPT-mediated activation of gene transcription remains unclear. In this study, we reveal that CREPT participates in transcription of the Wnt/β-catenin signaling activated genes through the β-catenin and the TCF4 complex. Our results demonstrate that CREPT interacts with both β-catenin and TCF4, and enhances the association of β-catenin with TCF4, in response to Wnt stimulation. Furthermore, CREPT was shown to occupy at TCF4 binding sites (TBS) of the promoters of Wnt-targeted genes under Wnt stimulation. Interestingly, depletion of CREPT resulted in decreased occupancy of β-catenin on TBS, and over-expression of CREPT enhances the activity of the β-catenin·TCF4 complex to initiate transcription of Wnt target genes, which results in up-regulated cell proliferation and invasion. Our study suggests that CREPT acts as an activator to promote transcriptional activity of the β-catenin·TCF4 complex in response to Wnt signaling.
Mir-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells

Xue-tao Li,Hang-zhou Wang,Zhi-wu Wu,Tian-quan Yang,Zhao-hui Zhao,Gui-lin Chen,Xue-shun Xie,Bin Li,Yong-xin Wei,Yu-lun Huang,You-xin Zhou,Zi-wei Du

DOI: https://doi.org/10.1007/s10571-015-0163-0

2015-01-01

Cellular and Molecular Neurobiology

Abstract:Malignant gliomas are the most common primary brain tumors, and the molecular mechanisms involving their progression and recurrence are still largely unclear. Substantial data indicate that the oncogene miR-494-3p is significantly elevated in gliomas, but the molecular functions of miR-494-3p in gliomagenesis are largely unknown. The present study aimed to explore the role of miR-494-3p and its molecular mechanism in human brain gliomas, malignant glioma cell lines, and cancer stem-like cells. The expression level of miR-494-3p in 48 human glioma issues and 8 normal brain tissues was determined using stem-loop real-time polymerase chain reaction (PCR). To study the function of miR-494-3p inhibitor in glioma cells, the miR-494-3p inhibitor lentivirus was used to transfect glioma cells. Transwell invasion system was used to estimate the effects of miR-494-3p inhibitor on the invasiveness of glioma cells. A mouse model was used to test the effect of miR-494-3p inhibitor on glioma proliferation and invasion in vivo. Results showed that the expression of miR-494-3p in human brain glioma tissues was higher than in normal brain tissues. Downregulated expression of miR-494-3p can inhibit the invasion and proliferation and promote apoptosis in glioma cells. Quantitative reverse transcription PCR and Western blotting analysis revealed that the expression of PTEN was increased after downexpression of miR-494-3p in glioma cells (U87 and U251). miR-494-3p inhibitor could prevent migration, invasion, proliferation, and promote apotosis in gliomas through PTEN/AKT pathway. Therefore, the study results have shown that miR-494-3p may act as a therapeutic target in gliomas.
Mir-138-5p Suppresses Glioblastoma Cell Viability and Leads to Cell Cycle Arrest by Targeting Cyclin D3.

Henggang Wu,Cheng Wang,Yajun Liu,Chao Yang,Xiaolong Liang,Xin Zhang,Xu Li

DOI: https://doi.org/10.3892/ol.2020.12127

2020-01-01

Oncology Letters

Abstract:Although malignant glioblastoma (GBM) treatment has significantly improved in the past few decades, the prognosis of GBM remains unsatisfactory. MicroRNA (miR)-138-5p has been reported as a tumor suppressor in several types of human cancer; however, little is known about the function of miR-138-5p in GBM. The present study aimed to investigate the role of miR-138-5p in GBM as well as the underlying molecular mechanisms. The present study performed bioinformatics analysis, reverse transcription-quantitative (RT-q)PCR, western blotting, cell viability assays, colony formation assays, invasion assays and cell cycle analysis to investigate the biological function of miR-138-5p in both patient tissues and cell lines. In addition, miR-138-5p targets in GBM were predicted using Gene Expression Omnibus website and further validated by a dual luciferase reporter gene assay. The results revealed that miR-138-5p expression levels in patients with GBM from a Gene Expression Omnibus dataset were significantly downregulated. RT-qPCR analysis of miR-138-5p expression levels also revealed similar results in GBM tissues and cell lines. The upregulation of miR-138-5p expression levels using a mimic significantly inhibited the cell viability, colony formation and the G0/G1 to S progression in GBM cell lines, suggesting that miR-138-5p may be a tumor suppressor. Moreover, miR-138-5p was discovered to directly target cyclin D3 (CCND3), a protein that serves an important role in the cell cycle, and inhibited its expression. Finally, silencing CCND3 using small interfering RNA suppressed the viability of GBM cells. In conclusion, the results of the present study suggested that miR-138-5p may function as a tumor suppressor in GBM by targeting CCND3, indicating that miR-138-5p may be a novel therapeutic target for patients with GBM.
Measuring interferon alpha and other cytokines in SLE.

M. Olferiev,Mari Lliguicota,K. Kirou,M. Crow

DOI: https://doi.org/10.1007/978-1-4939-0326-9_10

Abstract:
Expression of CREPT is Associated with Poor Prognosis of Patients with Renal Cell Carcinoma

Huaqi Yin,Qingfei Cao,Haiyue Zhao,Shenheng Wang,Weinan Chen,Xiaowei Zhang,Zhijie Chang,Tao Xu,Xiongjun Ye

DOI: https://doi.org/10.3892/ol.2019.10831

2019-01-01

Oncology Letters

Abstract:Cell-cycle-associated and expression-elevated protein in tumor (CREPT) functions as a cell cycle modulator that enhances the transcription of cyclin D1 by interacting with RNA polymerase II. CREPT has been identified to be overexpressed in various human cancer types; however, the expression and significance of CREPT in renal cell carcinoma (RCC) has remained largely elusive. In the present study, increased expression of CREPT was identified in 46.7% RCC tissues compared with adjacent normal tissue (31.1%; P=0.032) using immunohistochemistry. Furthermore, overexpression of CREPT was significantly associated with the Tumor-Node-Metastasis stage (χ2=11.967, P=0.001) and Fuhrman grade (χ2=15.453, P<0.001). In addition, increased expression of CREPT was associated with poor overall survival (P=0.021) and disease-free survival (P=0.015) of patients according to Kaplan-Meier analysis. Cellular function assays demonstrated that knockdown of CREPT in the 786-O and 769P RCC cell lines suppressed their proliferative, colony formation, migratory and invasive capacity and led to cell cycle arrest in the G1 phase. In addition, the western blotting analysis demonstrated that CREPT may control the cell cycle through downregulation of cyclin D1 and c-myc. Collectively, the overexpression of CREPT was indicated to be a negative prognostic factor for RCC, and CREPT may serve as a novel therapeutic target for the treatment of RCC.
CRNDE Promotes Malignant Progression of Glioma by Attenuating miR-384/PIWIL4/STAT3 Axis.

Jian Zheng,Xiaobai Liu,Ping Wang,Yixue Xue,Jun Ma,Chengbin Qu,Yunhui Liu

DOI: https://doi.org/10.1038/mt.2016.71

2016-01-01

Abstract:Colorectal neoplasia differentially expressed (CRNDE) is the most upregulated long noncoding RNA (lncRNA) in glioma. Herein, the function and potential molecular mechanisms of CRNDE and miR-384 were illustrated in glioma cells. CRNDE overexpression facilitated cell proliferation, migration, and invasion, while inhibited glioma cells apoptosis. Quantitative real-time polymerase chain reaction (PCR) demonstrated that miR-384 was downregulated in human glioma tissues and glioma cell lines. Moreover, restoration of miR-384 exerted tumor-suppressive functions. In addition, the expression of miR-384 was negatively correlated with CRNDE expression. A binding region between CRNDE and miR-384 was confirmed using luciferase assays. Moreover, CRNDE promoted cell malignant behavior by decreasing miR-384 expression. At the molecular level, treatment by CRNDE knockdown or miR-384 overexpression resulted in a decrease of piwi-like RNA-mediated gene silencing 4 (PIWIL4) protein. Besides, PIWIL4 was identified as a target of miR-384 and plays an oncogenic role in glioma. Similarly, downstream proteins of PIWIL4 such as STAT3, cyclin D1, VEGFA, SLUG, MMP-9, caspase 3, Bcl-2, and bcl-xL were modulated when treated with miR-384 and PIWIL4. Remarkably, CRNDE knockdown combined with miR-384 overexpression led to tumor regression in vivo. Overall, these results depicted a novel pathway mediated by CRNDE in glioma, which may be a potential application for glioma therapy.
MicroRNA‐383 Acts As a Tumor Suppressor in Colorectal Cancer by Modulating CREPT/RPRD1B Expression

Jian Li,Amber R. Smith,Rebecca T. Marquez,Jun Li,Kun Li,Lan,Xiaoqing Wu,Linxi Zhao,Fangli Ren,Yi Wang,Yinyin Wang,Baoqing Jia,Liang Xu,Zhijie Chang

DOI: https://doi.org/10.1002/mc.22866

2018-01-01

Molecular Carcinogenesis

Abstract:CREPT (Cell‐cycle‐related and expression‐elevated protein in tumor)/RPRD1B, a novel protein that enhances the transcription of Cyclin D1 to promote cell proliferation during tumorigenesis, was demonstrated highly expressed in most of tumors. However, it remains unclear how CREPT is regulated in colorectal cancers. In this study, we report that miR‐383 negatively regulates CREPT expression. We observed that CREPT was up‐regulated but the expression of miR‐383 was down regulated in both colon cancer cell lines and colon tumor tissues. Intriguingly, we found that enforced expression of miR‐383 inhibited the expression of CREPT at both the mRNA and protein level. Using a luciferase reporter, we showed that miR‐383 targeted the 3′‐UTR of CREPT mRNA directly. Consistently we observed that over expression of miR‐383 shortened the half‐life of CREPT mRNA in varieties of colorectal cancer cells. Furthermore, restoration of miR‐383 inhibited cell growth and colony formation of colon cancer cells accompanied by inhibition of expression of CREPT and related downstream genes. Finally, we demonstrated that stable over expression of miR‐383 in colon cancer cells decreased the growth of the tumors. Our results revealed that the abundant expression of CREPT in colorectal cancers is attributed to the decreased level of miR‐383. This study shed a new light on the potential therapeutic therapy strategy for colorectal cancers using introduced miRNA.
Mir-27a Regulates Wnt/Beta-Catenin Signaling Through Targeting Sfrp1 in Glioma

Kun Wang,Dajiang Xie,Jixi Xie,Yingfeng Wan,Li Ma,Xuchen Qi,Shuxu Yang

DOI: https://doi.org/10.1097/wnr.0000000000000410

2015-01-01

Neuroreport

Abstract:Glioma is one of the most common intracranial tumors, and the prognosis is poor, although more and more treatments are employed. Wnt/beta-catenin signaling has been reported to be associated with glioma. SFRP1 acts as an antagonist and inhibits Wnt signaling by binding to Wnt molecules. In the present study, we aimed to investigate miRNA-27a as an antineoplastic factor that inhibits the Wnt/beta-catenin pathway by binding to the SFRP1 3-UTR in glioma in vitro. We first showed that the expression of miR-27a was elevated in both glioma samples and cell lines. Furthermore, downregulation of miR-27a induced growth inhibition, cycle arrest, and apoptosis, and suppressed invasion/migration in glioma cell lines. Quantitative real-time PCR, western blot, and luciferase assay analysis showed that SFRP1 is a direct target of miR-27a. Overexpression of SFRP1 inhibited the malignancy of glioma cell lines. Our investigation showed that downregulation of miR-27a suppressed beta-catenin/TCF-4 transcription activity by targeting SFRP1. Our findings identify a role for miR-27a in glioma cell viability, cycle, apoptosis, and invasion/migration after activation of Wnt/beta-catenin signaling through SFRP1.
Inhibition of CREPT restrains gastric cancer growth by regulation of cycle arrest, migration and apoptosis via ROS-regulated p53 pathway

Miao Sun,Gao Si,Hai-Shen Sun,Fu-Chun Si

DOI: https://doi.org/10.1016/j.bbrc.2018.01.167

2018-02-19

Abstract:CREPT (cell-cycle related and expression-elevated protein in tumor) was reported to be associated with growth of several human cancers; however, its clinical significance and regulatory mechanism still remain unclear in human gastric cancer. In the present study, we found CREPT was significantly increased in gastric cancer tissues compared to the matched adjacent normal tissues. CREPT silence inhibited the proliferation of gastric cancer cells through inducing G0/G1 phase cell cycle arrest, which was linked to the reduction of Cyclin D1 and Cyclin D-dependent kinase 4 (CDK4), and the elevation of p53 and p21. In addition, CREPT knockdown (KD) decreased migration of gastric cancer cells through up-regulating E-cadherin and down-regulating vimentin, N-cadherin and matrix metalloproteinase 1 (MMP-1) expressions. Further, CREPT KD induced apoptosis in gastric cancer cells, as evidenced by the increase of cleaved Caspase-3 and poly (ADP-ribose) polymerase (PARP). Intriguingly, suppressing p53 expressions significantly abolished CREPT silence-induced apoptosis, and reduction of cell viability. Moreover, CREPT KD caused reactive oxygen species (ROS) generation using discounted cash flow (DCF) analysis, which was reversed by ROS scavenger, N-acetyl-l-cysteine (NAC), pretreatment. Of note, NAC pretreatment abrogated apoptotic cell death in CREPT KD gastric cancer cells. In vivo, suppressing CREPT reduced the gastric tumor growth in gastric cancer xenograft models. Altogether, our results provided a novel insight into CREPT in regulating gastric cancer progression through apoptosis regulated by ROS/p53 pathways.
Long non-coding RNA RMRP promotes human glioma tumor progression via miR-466/CXCR4 pathway

Jie Zhang,Ling He,Xun Xia,Lie Zhang,Enren Wang

DOI: https://doi.org/10.21203/rs.3.rs-315866/v1

2021-03-17

Abstract:Abstract Purpose: Long non-coding RNA (lncRNA) RMRP has been confirmed to be associated with multiple tumor progression. However, the molecular regulatory mechanism of RMRP in human glioma was rarely elucidated. Methods: The quantitative real-time polymerase chain reaction (qRT-PCR) was used to measure the expression levels of RMRP, microRNA-466 (miR-466) and CXCR4 in glioma tissues and cells. The ELISA-BrdU assay and flow cytometry analysis was used to perform the cell proliferation, apoptotic rate, cell cycle assay in human glioma cell lines A172 and U251 cells. The starBase v2.0 or TargetScan was used to predict the potential interactions among RMRP, miR-466 and CXCR4, and the luciferase reporter assay was performed to validate the relationship among these molecules. The western blot was used to determine the expression levels of protein associated with cell cycle and CXCR4. Results: The levels of RMRP, CXCR4 were highly expressed, but miR-466 was decreased in glioma tissues and cells. And miR-466 was verified as a direct target of RMRP and directly regulated CXCR4. RMRP expression or miR-466 inhibitor promote cell proliferation and G1/S cell cycle transition but reduced apoptotic rate in A172 and U251 cells, while RMRP promote G1/S cell cycle transition through regulating CDK4 pathway, not CDK2 pathway. And that, the introduction of CXCR4 partly counteracted these impacts. In addition, RMRP silencing and miR-466 mimic impeded xenograft tumor growth in vivo . Conclusion: RMRP enhanced glioma progression, partially through miR-466/CXCR4 pathway. The molecular regulation mechanism based on RMRP/miR-466/CXCR4 might contribute to the diagnosis of glioma and provide the effective therapeutic targets for its treatment.
MicroRNA-509-3p Inhibits Cell Proliferation and Invasion Via Downregulation of X-linked Inhibitor of Apoptosis in Glioma.

Peng Du,Xinping Luan,Yiwei Liao,Yiti Mu,Yang Yuan,Jingxuan Xu,Jingjing Zhang

DOI: https://doi.org/10.3892/ol.2017.7390

2017-01-01

Oncology Letters

Abstract:Malignant glioma is an aggressive type of cancer. Increasing evidence has suggested that microRNAs (miRs) regulate gene expression post-transcriptionally to affect cancer development and progression. Aberrant expression of miR-509-3p has been reported in cancer studies. However, the expression and mechanism of its function in glioma remains unclear. The present study demonstrated that miR-509-3p was downregulated in glioma tissue samples relative to non-tumor tissues, and that low miR-509-3p expression was associated with a reduced overall survival time. Functional studies revealed that the overexpression of miR-509-3p inhibited cell proliferation, induced apoptosis and suppressed cell migration and invasion via negatively regulating the expression of X-linked inhibitor of apoptosis. The data therefore suggested that miR-509-3p serves an important role in the development and progression of glioma, implicating its possible application in clinical practice as a biomarker and a potential novel therapeutic target.
Evaluation of glucose oxidase strip method of blood glucose testing.

D. Delawter,J. Moss

Abstract:
Up-regulation of the long non-coding RNA RMRP contributes to glioma progression and promotes glioma cell proliferation and invasion.

Wenxian Feng,Li Li,Xuchang Xu,Yunqi Jiao,Wei Du

DOI: https://doi.org/10.5114/aoms.2017.66747

2017-01-01

Abstract:INTRODUCTION:Gliomas are the most common malignant tumors of the brain. Long non-coding RNAs (lncRNAs) play key regulatory roles in various tumors. In this study, we aimed to determine the expression and biological roles of lncRNA RMRP in glioma. MATERIAL AND METHODS:The relative expression level of lncRNA RMRP was determined by quantitative real-time polymerase chain reaction (qRT-PCR) in a total of 39 patients with glioma. RNA interference (RNAi) approaches were used to investigate the biological functions of RMRP. The effect of lncRNA RMRP on proliferation was determined by CCK8 assay. Cell cycle and apoptosis were evaluated by flow cytometry analysis. Cell migration was explored by the wound-healing assay. Cell invasion was investigated by the Transwell invasion assay. RESULTS:LncRNA RMRP was up-regulated in human glioma tissues compared with normal brain tissues (p < 0.05). LncRNA RMRP up-regulation was significantly correlated with advanced tumor grade and low Karnofsky Performance Score (KPS) (p < 0.05). Moreover, patients with a high expression level of lncRNA RMRP had a relatively poor prognosis (p < 0.05). Multivariate analyses revealed that lncRNA RMRP expression served as an independent predictor for overall survival of glioma patients (p < 0.05). In addition, inhibition of lncRNA RMRP by RNAi significantly suppressed the proliferation, migration and invasion of glioma cells in vitro (p < 0.05). CONCLUSIONS:lncRNA RMRP might act as an oncogene and could be used as a therapeutic target for the treatment of glioma. Our findings provide an in-depth insight into the role of lncRNA RMRP in glioma progression.

Does Neurologic Examination During Inpatient Rehabilitation Help Predict Global Outcome After Nonpenetrating Traumatic Brain Injury?

An Oncoprotein CREPT Functions As a Co-Factor in MYC-driven Transformation and Tumor Growth

miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase.

CREPT Promotes Melanoma Progression Through Accelerated Proliferation and Enhanced Migration by RhoA-Mediated Actin Filaments and Focal Adhesion Formation

CREPT accelerates tumorigenesis by regulating the transcription of cell-cycle-related genes.

CREPT facilitates colorectal cancer growth through inducing Wnt/β-catenin pathway by enhancing p300-mediated β-catenin acetylation

MicroRNA-449b-5p suppresses the growth and invasion of breast cancer cells via inhibiting CREPT-mediated Wnt/β-catenin signaling

Crept/Rprd1b, A Recently Identified Novel Protein Highly Expressed in Tumors, Enhances the Beta-Catenin Center Dot Tcf4 Transcriptional Activity in Response to Wnt Signaling

CREPT/RPRD1B, a Recently Identified Novel Protein Highly Expressed in Tumors, Enhances the Β-Catenin·tcf4 Transcriptional Activity in Response to Wnt Signaling.

Mir-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells

Mir-138-5p Suppresses Glioblastoma Cell Viability and Leads to Cell Cycle Arrest by Targeting Cyclin D3.

Measuring interferon alpha and other cytokines in SLE.

Expression of CREPT is Associated with Poor Prognosis of Patients with Renal Cell Carcinoma

CRNDE Promotes Malignant Progression of Glioma by Attenuating miR-384/PIWIL4/STAT3 Axis.

MicroRNA‐383 Acts As a Tumor Suppressor in Colorectal Cancer by Modulating CREPT/RPRD1B Expression

Mir-27a Regulates Wnt/Beta-Catenin Signaling Through Targeting Sfrp1 in Glioma

Inhibition of CREPT restrains gastric cancer growth by regulation of cycle arrest, migration and apoptosis via ROS-regulated p53 pathway

Long non-coding RNA RMRP promotes human glioma tumor progression via miR-466/CXCR4 pathway

MicroRNA-509-3p Inhibits Cell Proliferation and Invasion Via Downregulation of X-linked Inhibitor of Apoptosis in Glioma.

Evaluation of glucose oxidase strip method of blood glucose testing.

Up-regulation of the long non-coding RNA RMRP contributes to glioma progression and promotes glioma cell proliferation and invasion.